Relationship between polymorphism Ser 89 Asn of UTS 2 gene and atherosclerotic cerebral infarction in Chinese Hunan Han population

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Ischemic stroke as a complex polygenic disease

  2015cited by this paper
• Urotensin II Promotes Atherosclerosis in Cholesterol-Fed Rabbits

  2014cited by this paper
• Current concepts and clinical applications of stroke genetics.

  2014cited by this paper
• Multilocus Genetic Risk Score Associates With Ischemic Stroke in Case–Control and Prospective Cohort Studies

  2014cited by this paper
• [Urotensin II--a newly discovered modulator of cardiovascular functions in vertebrates].

  2013cited by this paper
• Epidemiological Factors of Stroke: A Survey of the Current Status in China

  2013cited by this paper
• Association between Human Urotensin II and Essential Hypertension—A 1:1 Matched Case-Control Study

  2013cited by this paper
• Urotensin-II System in Genetic Control of Blood Pressure and Renal Function

  2013cited by this paper
• Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes

  2013cited by this paper
• Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation.

  2012influential reference
• Platelet glycoprotein IIb/IIIa polymorphism HPA-3 b/b is associated with increased risk of ischemic stroke in patients under 60 years of age

  2012cited by this paper
• Urotensin II promotes the proliferation of endothelial progenitor cells through p38 and p44/42 MAPK activation.

  2012cited by this paper
• Genetic and Pharmacological Manipulation of Urotensin II Ameliorate the Metabolic and Atherosclerosis Sequalae in Mice

  2012cited by this paper
• Urotensin II, from fish to human

  2010cited by this paper
• Role of urotensin II in health and disease.

  2010cited by this paper
• Cardiorenovascular effects of urotensin II and the relevance of the UT receptor.

  2008cited by this paper
• Role of urotensin II and its receptor in health and disease

  2007cited by this paper
• Proliferation and anti-apoptotic effects of human urotensin II on human endothelial cells.

  2006influential reference
• Abstract 3000: Increased Human Urotensin II Levels are Correlated With Carotid Atherosclerosis in Essential Hypertension

  2006cited by this paper
• Human Urotensin II Accelerates Foam Cell Formation in Human Monocyte-Derived Macrophages

  2005influential reference
• Human Urotensin II Is a Novel Activator of NADPH Oxidase in Human Pulmonary Artery Smooth Muscle Cells

  2005influential reference
• Urotensin II: Its Function in Health and Its Role in Disease

  2005cited by this paper
• Urotensin II-induced hypotensive responses in Wistar-Kyoto (Wky) and spontaneously hypertensive (Shr) rats.

  2005cited by this paper
• Human Urotensin II Modulates Collagen Synthesis and the Expression of MMP-1 in Human Endothelial Cells

  2004influential reference
• Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects

  2003cited by this paper
• [The role of urotensin II gene in the genetic susceptibility to type 2 diabetes in Chinese population].

  2002cited by this paper
• Effects of Urotensin II in Human Arteries and Veins of Varying Caliber

  2001cited by this paper
• Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease.

  2000cited by this paper

• No citing papers are available for this paper.